ATXN7 antibody (Middle Region)
Quick Overview for ATXN7 antibody (Middle Region) (ABIN927440)
Target
See all ATXN7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Cross-Reactivity
- Rat (Rattus), Mouse (Murine), Dog (Canine), Chicken
-
Purification
- Purified
-
Immunogen
- ATXN7 antibody was raised in rabbit using the middle region of ATXN7 as the immunogen
-
-
-
-
Application Notes
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
ATXN7 Blocking Peptide, (ABIN5612243), is also available for use as a blocking control in assays to test for specificity of this ATXN7 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- ATXN7 (Ataxin 7 (ATXN7))
-
Alternative Name
- ATXN7
-
Background
- ATXN7 is involved in neurodegeneration. ATXN7 acts as component of the STAGA transcription coactivator-HAT complex. ATXN7 mediates the interaction of STAGA complex with the CRX and is involved in CRX-dependent gene activation.The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Synonyms: Polyclonal ATXN7 antibody, Anti-ATXN7 antibody, ataxin 7 antibody, ADCAII antibody, OPCA3 antibody, SCA7 antibody.
Target
-